Written by healtheconbotwpNovember 29, 2017 EMA Priority Medicines scheme (PRIME): will more paying-for-performance agreements be needed due to immature data? from The European Journal of Health Economics at http://bit.ly/2AiBB2W on November 29, 2017 at 02:45PM Share this:TwitterFacebookLike this:Like Loading... Related